Review: taking Metoprolol tartrate and Pravastatin sodium together


Summary

Drug interactions are reported among people who take Metoprolol tartrate and Pravastatin sodium together. This review analyzes the effectiveness and drug interactions between Metoprolol tartrate and Pravastatin sodium. It is created by eHealthMe based on reports of 4,891 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 46,720 users)

Pravastatin Sodium

Pravastatin sodium has active ingredients of pravastatin sodium. It is often used in hyperlipidaemia. (latest outcomes from Pravastatin sodium 11,956 users)

On Sep, 21, 2016

4,891 people who take Metoprolol Tartrate, Pravastatin Sodium are studied.


Number of reports submitted per year:

Metoprolol tartrate and Pravastatin sodium drug interactions.

Drug effectiveness over time:

Metoprolol Tartrate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (6 of 12 people)
  • 6 - 12 months: 33.0% - (2 of 6 people)
  • 1 - 2 years: 21.0% - (3 of 14 people)
  • 2 - 5 years: 48.0% - (15 of 31 people)
  • 5 - 10 years: 55.0% - (5 of 9 people)
  • 10+ years: 75.0% - (6 of 8 people)
  • not specified: 100.0% - (1 of 1 people)
Pravastatin Sodium:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 23.0% - (3 of 13 people)
  • 6 - 12 months: 30.0% - (3 of 10 people)
  • 1 - 2 years: 38.0% - (7 of 18 people)
  • 2 - 5 years: 42.0% - (8 of 19 people)
  • 5 - 10 years: 10.0% - (1 of 10 people)
  • 10+ years: 66.0% - (2 of 3 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Metoprolol Tartrate:
  • female: 43.0% - (16 of 37 people)
  • male: 50.0% - (22 of 44 people)
Pravastatin Sodium:
  • female: 40.0% - (14 of 35 people)
  • male: 30.0% - (12 of 40 people)

Drug effectiveness by age:

Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 57.0% - (4 of 7 people)
  • 50-59: 41.0% - (10 of 24 people)
  • 60+: 45.0% - (22 of 48 people)
Pravastatin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 14.0% - (1 of 7 people)
  • 50-59: 18.0% - (4 of 22 people)
  • 60+: 43.0% - (19 of 44 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • fatigue
  • asthenia
  • dyspnoea
  • oedema peripheral
  • dysarthria
  • bradycardia
  • confusional state
  • decreased appetite
  • hypotension
1 - 6 months:
  • acquired afibrinogenaemia
  • stevens-johnson syndrome
  • chest pain
  • fatigue
  • ventricular tachycardia
  • anaemia
  • anxiety
  • cardiomegaly
  • death
  • myocardial infarction
6 - 12 months:
  • haematoma
  • lactic acidosis
  • peripheral vascular disorder
  • puncture site haemorrhage
  • sepsis syndrome
  • febrile neutropenia
  • fever
  • anxiety
  • blood pressure fluctuation
  • burning feet syndrome
1 - 2 years:
  • acquired afibrinogenaemia
  • shortness of breath
  • bursitis
  • anxiety
  • benign prostatic hyperplasia
  • dermatitis contact
  • fall
  • intervertebral disc protrusion
  • nervous system disorder
  • concussion
2 - 5 years:
  • dizziness
  • myocardial infarction
  • gastrointestinal haemorrhage
  • anxiety
  • diarrhea associated with medications
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • mental status - decreased
  • muscle weakness
  • vision problems
  • fatigue
5 - 10 years:
  • gastrointestinal haemorrhage
  • renal failure acute
  • weight gain
  • blood creatine phosphokinase increased
  • cerebral haemorrhage
  • haemothorax
  • hypotension
  • malaise
  • myalgia
  • myocardial infarction
10+ years:
  • depression
  • fatigue
  • myocardial infarction
  • angina unstable
  • anxiety
  • bronchitis
  • chest pain
  • coronary artery disease
  • dental caries
  • diabetes mellitus
not specified:
  • dyspnoea
  • fatigue
  • pain
  • nausea
  • myocardial infarction
  • diarrhoea
  • dizziness
  • drug ineffective
  • chest pain
  • asthenia

Most common drug interactions by gender *:

female:
  • pain
  • fatigue
  • dyspnoea
  • nausea
  • anaemia
  • diarrhoea
  • chest pain
  • drug ineffective
  • myocardial infarction
  • fall
male:
  • dyspnoea
  • myocardial infarction
  • fatigue
  • nausea
  • dizziness
  • asthenia
  • hypotension
  • pneumonia
  • diarrhoea
  • pain

Most common drug interactions by age *:

0-1:
  • aorta hypoplasia
  • atrial septal defect
  • coarctation of the aorta
  • mitral valve hypoplasia
  • congenital aortic valve stenosis
  • aortic valve stenosis
  • congenital aortic stenosis
  • congenital heart valve disorder
  • ventricular septal defect
  • foetal exposure during pregnancy
2-9:
  • cellulitis
  • clostridium difficile colitis
  • irritability
  • withdrawal syndrome
  • application site urticaria
  • fungal peritonitis
  • infection
  • rash
10-19:
  • cataract
  • cerebral haemorrhage
  • dysuria
  • fall
  • head injury
  • prostatic disorder
  • type 2 diabetes mellitus
  • urinary tract infection
  • urosepsis
  • visual acuity reduced
20-29:
  • arthralgia
  • cough
  • productive cough
  • sinus congestion
  • upper respiratory tract infection
  • weight increased
  • abortion spontaneous
  • maternal exposure during pregnancy
  • adverse drug reaction
  • blood creatinine increased
30-39:
  • hypotension
  • myocardial infarction
  • pain in extremity
  • dyspnoea
  • chest pain
  • pain
  • gait disturbance
  • hypertension
  • oedema peripheral
  • malaise
40-49:
  • chest pain
  • nausea
  • pain
  • fatigue
  • vomiting
  • injury
  • cardiac failure congestive
  • myocardial infarction
  • drug ineffective
  • dyspnoea
50-59:
  • myocardial infarction
  • pain
  • nausea
  • dyspnoea
  • anxiety
  • chest pain
  • pain in extremity
  • arthralgia
  • fatigue
  • drug ineffective
60+:
  • fatigue
  • dyspnoea
  • pain
  • nausea
  • dizziness
  • anaemia
  • diarrhoea
  • asthenia
  • pleural effusion
  • myocardial infarction

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol tartrate and Pravastatin sodium?

Can you answer these questions?

More questions for: Metoprolol tartrate, Pravastatin sodium

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Pravastatin sodium

On eHealthMe, Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Pravastatin sodium (pravastatin sodium) is often used to treat hyperlipidaemia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.